Platelet receptor expression and shedding: Glycoprotein Ib-IX-V and glycoprotein VI

Transfusion Medicine Reviews

Volumn 28, Issue 2, 2014, Pages 56-60

  Gardiner, Elizabeth E ^a   Andrews, Robert K ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Glycoprotein Ib; Glycoprotein VI; Hemostasis; Platelets; Thrombosis

Indexed keywords

GLYCOPROTEIN IB; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN VI; THROMBOCYTE RECEPTOR; FIBRINOGEN RECEPTOR; PLATELET MEMBRANE GLYCOPROTEIN VI; THROMBIN RECEPTOR;

BLOOD SAMPLING; CLEARANCE; HUMAN; LOW TEMPERATURE; NONHUMAN; PLATELET CLEARANCE; PLATELET RECEPTOR SHEDDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVIEW; THROMBOCYTE FUNCTION; THROMBOCYTE LIFESPAN; THROMBOCYTE TRANSFUSION; THROMBOCYTOPOIESIS; BLOOD PLATELET DISORDERS; BLOOD TRANSFUSION; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; PROCEDURES; PROTEIN TERTIARY STRUCTURE; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; BLOOD TRANSFUSION; GENE EXPRESSION REGULATION; HUMANS; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN STRUCTURE, TERTIARY; THROMBOCYTOPENIA; THROMBOSIS;

EID: 84899491184     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2014.03.001     Document Type: Review

References (90)

1. Moiz B., Rashid A. BSS misdiagnosed as ITP. Blood 2013, 122(10):1693.
2. Bernard J., Soulier J.-P. Sur une nouvelle variété de dystrophie thrombocytairehémorragipare congénitale. Sem Hop 1948, 24:3217-3223.
3. López J.A., Andrews R.K., Afshar-Kharghan V., Berndt M.C. Bernard-Soulier syndrome. Blood 1998, 91:4397-4418.
4. Berndt M.C., Andrews R.K. Bernard-Soulier syndrome: an update. Sem Thromb Haemost 2013, 39(6):656-662.
5. Althaus K., Greinacher A. MYH-9 related platelet disorders: strategies for management and diagnosis. Transfus Med Hemother 2010, 3(5):260-267.
6. Lakshmanan S., Cuker A. Contemporary management of primary immune thrombocytopenia in adults. J Thromb Haemost 2012, 10(10):1988-1998.
7. Rodrigo C., Gooneratne L. Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review. J Thromb Haemost 2013, 11(11):1946-1953.
8. Ombrello C., Block R., Morrell C. Our expanding view of platelet functions and its clinical implications. J Cardiovasc Transl Res 2010, 3(5):538-546.
9. Riedl J., Pabinger I., Ay C. Platelets in cancer and thrombosis. Hamostaseologie 2014, 34(1):54-62.
10. Versteeg H.H., Heemskerk J.W., Levi M., Reitsma P.H. New fundamentals in hemostasis. Physiol Rev 2013, 93(1):327-358.
11. Zhang W., Huang W., Jing F. Contribution of blood platelets to vascular pathology in Alzheimer's disease. J Blood Med 2013, 4:141-147.
12. Andrews R.K., Berndt M.C., Elalamy I. Platelets: from function to dysfunction in essential thrombocythaemia. Eur Haematol Oncol 2011, 7(2):125-131.
13. Dowling M.R., Josefsson E.C., Henley K.J., Hodgkin P.D., Kile B.T. Platelet senescence is regulated by an internal timer, not damage inflicted by hits. Blood 2010, 116(10):1776-1778.
14. Rumjantseva V., Grewal P.K., Wandall H.H., Josefsson E.C., Sørensen A.L., Larson G., et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med 2009, 15(11):1273-1280.
15. Jansen A.J.G., Josefsson E.C., Rumjantseva V., Liu Q.P., Falet H., Bergmeier W., et al. Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice. Blood 2012, 119(5):1263-1273.
16. Andrews R.K., Berndt M.C. Platelet physiology and thrombosis. Thromb Res 2004, 114:447-453.
17. Andrews R.K., Berndt M.C. The glycoprotein Ib-IX-V complex. Platelets 2012, 195-211. Academic Press, San Diego. 3rd ed. A. Michelson (Ed.).
18. Andrews R.K., Du X., Berndt M.C. The 14-3-3ζ-GPIb-IX-V complex as an antiplatelet target. Drug News Perspect 2007, 20:285-292.
19. Mu F.-T., Andrews R.K., Arthur J.F., Munday A.M., Cranmer S.L., Jackson S.P., et al. A functional 14-3-3ζ-independent association of PI3-kinase with glycoprotein Ibα, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex. Blood 2008, 111:4580-4587.
20. Mu F.-T., Cranmer S.L., Andrews R.K., Berndt M.C. Functional association of PI3-kinase with platelet glycoprotein Ibα, the major ligand-binding subunit of the glycoprotein Ib-IX-V complex. J Thromb Haemost 2010, 8:324-330.
21. Moog S., Mangin P., Lenain N., Strassel C., Ravanat C., Schuhler S., et al. Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 2001, 98(4):1038-1046.
22. Azorsa D.O., Moog S., Ravanat C., Schuhler S., Folléa G., Cazenave J.P., et al. Measurement of GPV released by activated platelets using a sensitive immunocapture ELISA-its use to follow platelet storage in transfusion. Thromb Haemost 1999, 81(1):131-138.
23. Ravanat C., Freund M., Mangin P., Azorsa D.O., Schwartz C., Moog S., et al. GPV is a marker of in vivo platelet activation-study in a rat thrombosis model. Thromb Haemost 2000, 83(2):327-333.
24. Javela K., Eronen J., Sarna S., Kekomäki R. Soluble glycoprotein V as a quality marker of platelet concentrates stressed by transportation. Transfusion 2005, 45(9):1504-1511.
25. Rabie T., Strehl A., Ludwig A., Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 2005, 280(15):14462-14468.
26. Gardiner E.E., Karunakaran D., Shen Y., Andrews R.K., Berndt M.C. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 2007, 5:1530-1537.
27. Ozaki Y., Suzuki-Inoue K., Inoue O. Platelet receptors activated via mulitmerization: glycoprotein VI, GPIb-IX-V, and CLEC-2. J Thromb Haemost 2013, 11(Suppl. 1):330-339.
28. Zahid M., Mangin P., Loyau S., Hechler B., Billiald P., Gachet C., et al. The future of glycoprotein VI as an antithrombotic target. J Thromb Haemost 2012, 10(12):2418-2427.
29. Dütting S., Bender M., Nieswandt B. Platelet GPVI: a target for antithrombotic therapy?!. Trends Pharmacol Sci 2012, 33(11):583-590.
30. Arthur J.F., Matzaris M., Gardiner E.E., Taylor S.G., Wijeyewickrema L.C., Ozaki Y., et al. Glycoprotein (GP)VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemost 2005, 93:716-723.
31. Bergmeier W., Stefanini L. Platelet ITAM signaling. Curr Opin Hematol 2013, 20(5):445-450.
32. Gardiner E.E., Karunakaran D., Arthur J.F., Mu F.-T., Powell M.S., Baker R.I., et al. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: De-ITAM-ising FcγRIIa. Blood 2008, 111:165-174.
33. Gardiner E.E., Arthur J.F., Shen Y., Karunakaran D., Moore L.A., Am Esch II Schulte, et al. GPIbα-selective activation of platelets induces platelet signalling events comparable to GPVI activation events. Platelets 2010, 21:244-252.
34. Andrews R.K., Karunakaran D., Gardiner E.E., Berndt M.C. Platelet receptor shedding: a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 2007, 27:1511-1520.
35. Al-Tamimi M., Grigoriadis G., Tran H., Paul E., Servadei P., Berndt M.C., et al. Coagulation-induced shedding of platelet glycoprotein VI mediated by Factor Xa. Blood 2011, 117(14):3912-3920.
36. Al-Tamimi M., Tan C.W., Qiao J., Pennings G.J., Javadzadegan A., Yong A.S.C., et al. Pathological shear triggers shedding of vascular receptors: a novel mechanism for downregulation of platelet glycoprotein (GP)VI in stenosed coronary vessels. Blood 2012, 119(18):4311-4320.
37. Bergmeier W., Piffath C.L., Cheng G., Dole V.S., Zhang Y., von Andrian U.H., et al. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIbα shedding from platelets in vitro and in vivo. Circ Res 2004, 95(7):677-683.
38. Bender M., Hofmann S., Stegner D., Chalaris A., Bösl M., Braun A., et al. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 2010, 116(17):3347-3355.
39. Al Tamimi M., Arthur J.F., Gardiner E.E., Andrews R.K. Focusing on plasma GPVI. Thromb Haemost 2012, 107(4):648-655.
40. Gardiner E.E., Andrews R.K. Plasma sGPVI: changing levels in human disease. Thromb Res 2014, 133(3):306-307.
41. Qiao J., Shen Y., Gardiner E.E., Andrews R.K. Proteolysis of platelet receptors in humans and other species. Biol Chem 2010, 391:893-900.
42. Bigalke B., Elvers M., Schönberger T., Gawaz M. Platelet and soluble glycoprotein VI-novel applications in diagnosis and therapy. Curr Drug Targets 2011, 12(12):1821-1830.
43. Brill A., Chauhan A.K., Canault M., Walsh M.T., Bergmeier W., Wagner D.D. Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res 2009, 84(1):137-144.
44. Al-Tamimi M., Mu F.T., Moroi M., Gardiner E.E., Berndt M.C., Andrews R.K. Measuring soluble platelet glycoprotein VI in human plasma by ELISA. Platelets 2009, 20:143-149.
45. Bigalke B., Pötz O., Kremmer E., Geisler T., Seizer P., Puntmann V.O., et al. Sandwich immunoassay for soluble glycoprotein VI in patients with symptomatic coronary artery disease. Clin Chem 2011, 57(6):898-904.
46. Yamashita Y., Naitoh K., Wada H., Ikejiri M., Mastumoto T., Ohishi K., et al. Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy. Thromb Res 2014, 133(3):440-444.
47. Qiao J., Schoenwaelder S.M., Mason K., Tran H., Davis A.K., Jackson S.P., et al. Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases prior to receiving Navitoclax (ABT-263). Blood 2013, 121(8):1479-1481.
48. Kunishima S., Hayashi K., Kobayashi S., Naoe T., Ohno R. New enzyme-linked immunosorbent assay for glycocalicin in plasma. Clin Chem 1991, 37(2):169-172.
49. Bessos H., Murphy W.G. A new competitive binding enzyme-linked immunosorbent assay for glycocalicin in plasma and platelet concentrate supernatants. Thromb Res 1990, 59(3):497-507.
50. Adelman B., Michelson A.D., Loscalzo J., Greenberg J., Handin R.I. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions. Blood 1985, 65(1):32-40.
51. Coller B.S., Kalomiris E., Steinberg M., Scudder L.E. Evidence that glycocalicin circulates in normal plasma. J Clin Invest 1984, 73:794-799.
52. Steinberg M.H., Kelton J.G., Coller B.S. Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders. N Engl J Med 1987, 317(17):1037-1042.
53. Burkhart J.M., Vaudel M., Gambaryan S., Radau S., Walter U., Martens L., et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012, 120(15):e73-e82.
54. Gardiner E.E., Al-Tamimi M., Mu F.T., Karunakaran D., Thom J.Y., Moroi M., et al. Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura. J Thromb Haemost 2008, 6(7):1175-1182.
55. Duerschmied D., Canault M., Lievens D., Brill A., Cifuni S.M., Bader M., et al. Serotonin stimulates platelet receptor shedding by tumor necrosis factor-α-converting enzyme (ADAM17). J Thromb Haemost 2009, 7(7):1163-1171.
56. Mo X., Nguyen N.X., Mu F.T., Yang W., Luo S.Z., Fan H., et al. Transmembrane and trans-subunit regulation of ectodomain shedding of platelet glycoprotein Ibα. J Biol Chem 2010, 285(42):32096-32104. [15].
57. Cheng H., Yan R., Li S., Yuan Y., Liu J., Ruan C., et al. Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibα shedding. Am J Physiol Heart Circ Physiol 2009, 297(6):H2128-H2135.
58. Forestier M., Al-Tamimi M., Gardiner E.E., Hermann C., Meyer S.C., Beer J.H. Diesel exhaust particles impair platelet response to collagen and are associated with GPIbα shedding. Toxicol In Vitro 2012, 26(6):930-938.
59. Aktas B., Pozgajova M., Bergmeier W., Sunnarborg S., Offermanns S., Lee D., et al. Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biol Chem 2005, 280(48):39716-39722.
60. Kojro E., Gimpl G., Lammich S., Marz W., Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10. Proc Natl Acad Sci U S A 2001, 98(10):5815-5820.
61. Murai T., Maruyama Y., Mio K., Nishiyama H., Suga M., Sato C. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J Biol Chem 2011, 286(3):1999-2007.
62. Bigalke B., Stellos K., Geisler T., Kremmer E., Seizer P., May A.E., et al. Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke. Eur J Neurol 2010, 17(1):111-117.
63. Al-Tamimi M., Gardiner E.E., Thom J.Y., Shen Y., Cooper M.N., Hankey G.J., et al. Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke. Stroke 2011, 42(2):498-500.
64. Wurster T., Poetz O., Stellos K., Kremmer E., Melms A., Schuster A., et al. Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke. Platelets 2013, 24(7):560-565.
65. Bigalke B., Stellos K., Geisler T., Lindemann S., May A.E., Gawaz M. Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease. Clin Res Cardiol 2010, 99(4):227-233.
66. Bigalke B., Stellos K., Weig H.J., Geisler T., Seizer P., Kremmer E., et al. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS). Basic Res Cardiol 2009, 104(3):352-357.
67. Pennings G.J., Yong A.S.C., Wong C., Al-Tamimi M., Gardiner E.E., Andrews R.K., et al. Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma. Platelets 2013, [in press]. 10.3109/09537104.2013.852660.
68. Nurden P., Tandon N., Takizawa H., Couzi L., Morel D., Fiore M., et al. An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis. J Thromb Haemost 2009, 7(9):1541-1549.
69. Gardiner E.E., Thom J.Y., Al-Tamimi M., Hughes A., Berndt M.C., Andrews R.K., et al. Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura. Br J Haematol 2010, 149(4):625-628.
70. Laske C., Leyhe T., Stransky E., Eschweiler G.W., Bueltmann A., Langer H., et al. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease. J Psychiatr Res 2008, 42(9):746-751.
71. Barsam S.J., Psaila B., Forestier M., Page L.K., Sloane P.A., Geyer J.T., et al. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia (ITP). Blood 2011, 117(21):5723-5732.
72. Psaila B., Bussel J.B., Linden M.D., Babula B., Li Y., Barnard M.R., et al. In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation. Blood 2012, 119(17):4066-4072.
73. Blann A.D., Lanza F., Galajda P., Gurney D., Moog S., Cazenave J.P., et al. Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis-the influence of aspirin and cigarette smoking. Thromb Haemost 2001, 86(3):777-783.
74. Morel O., Hugel B., Jesel L., Lanza F., Douchet M.P., Zupan M., et al. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost 2004, 91(2):345-353.
75. Acar K., Sucak A., Beyazit Y., Genc G., Haznedaroglu I.C., Aksu S., et al. Lack of platelet activation reflected by circulating soluble glycoprotein V in pre-eclampsia. J Int Med Res 2007, 35(5):704-708.
76. Falcinelli E., Francisci D., Belfiori B., Petito E., Guglielmini G., Malincarne L., et al. In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. Thromb Haemost 2013, 110(2):349-357.
77. Hoffmeister K.M., Felbinger T.W., Falet H., Denis C.V., Bergmeier W., Mayadas T.N., et al. The clearance mechanism of chilled blood platelets. Cell 2003, 112(1):87-97.
78. Rumjantseva V., Hoffmeister K.M. Novel and unexpected clearance mechanisms for cold platelets. Transfus Apher Sci 2010, 42(1):63-70.
79. Hoffmeister K.M., Josefsson E.C., Isaac N.A., Clausen H., Hartwig J.H., Stossel T.P. Glycosylation restores survival of chilled blood platelets. Science 2003, 301(5639):1531-1534.
80. Grewal P.K. The Ashwell-Morell receptor. Methods Enzymol 2010, 479:223-241.
81. Grewal P.K., Uchiyama S., Ditto D., Varki N., Le D.T., Nizet V., et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 2008, 14(6):648-655.
82. Fox J.E. Shedding of adhesion receptors from the surface of activated platelets. Blood Coagul Fibrinolysis 1994, 5(2):291-304.
83. Bergmeier W., Burger P.C., Piffath C.L., Hoffmeister K.M., Hartwid J.H., Nieswandt B., et al. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood 2003, 102(12):4229-4235.
84. Josefsson E.C., James C., Henley K.J., Debrincat M.A., Rogers K.L., Dowling M.R., et al. Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets. J Exp Med 2011, 208(10):2017-2031.
85. Canault M., Duerschmied D., Brill A., Stefanini L., Schatzberg D., Cifuni S.M., et al. p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo. Blood 2010, 115(9):1835-1842.
86. van der Wal D.E., Du V.X., Lo K.S., Rasmussen J.T., Verhoef S., Akkerman J.W. Platelet apoptosis by cold-induced glycoprotein Ibα clustering. J Thromb Haemost 2010, 8(11):2554-2562.
87. Gitz E., Koekman C.A., van den Heuvel D.J., Deckmyn H., Akkerman J.W., Gerritsen H.C., et al. Improved platelet survival after cold storage by prevention of glycoprotein Ibα clustering in lipid rafts. Haematologica 2012, 97(12):1873-1881.
88. Yuan Y., Zhang W., Yan R., Liao Y., Zhao L., Ruan C., et al. Identification of a novel 14-3-3ζ binding site within the cytoplasmic domain of platelet glycoprotein Ibα that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Circ Res 2009, 105(12):1177-1185.
89. van der Wal D.E., Gitz E., Du V.X., Lo K.S., Koekman C.A., Versteeg S., et al. Arachidonic acid depletion extends survival of cold-stored platelets by interfering with the [glycoprotein Ibα-14-3-3ζ] association. Haematologica 2012, 97(10):1514-1522.
90. Kruss S., Erpenbeck L., Amschler K., Mundinger T.A., Helms H.-J., Friede T., et al. Adhesion maturation of neutrophils on nanoscopically presented platelet receptor GPIbα. ACS Nano 2013, 7(11):9984-9996.